Valuation: Genix Pharmaceuticals Corporation

Market Cap 1.22M 882K 757K 710K 649K 84.11M 1.23M 8.41M 3.26M 42.43M 3.31M 3.24M 141M P/E 2024
-40.5x
P/E 2025 -5.33x
Enterprise Value 2.22M 1.6M 1.37M 1.29M 1.18M 153M 2.23M 15.27M 5.92M 77.06M 6.01M 5.88M 255M EV / Sales 2024
929,496,174x
EV / Sales 2025 -
Free-Float
53.08%
Yield 2024 *
-
Yield 2025 -
1 day+33.33%
1 week+33.33%
Current month+33.33%
1 month+33.33%
3 months+33.33%
Current year-20.00%
1 week 0.02
Extreme 0.02
0.02
1 month 0.02
Extreme 0.02
0.02
Current year 0.02
Extreme 0.015
0.02
1 year 0.02
Extreme 0.015
0.04
3 years 0.02
Extreme 0.015
0.09
5 years 0.02
Extreme 0.015
0.2
10 years 0.01
Extreme 0.01
0.3
Manager TitleAgeSince
Chief Executive Officer 57 2018-08-02
President - 2021-05-20
Corporate Officer/Principal 44 2019-09-04
Director TitleAgeSince
Director/Board Member 57 2018-08-02
Director/Board Member 76 2019-03-10
Director/Board Member 44 2019-09-04
Date Insider Type Main position Quantity % Market Cap.
9/9/25 Option

Chairman

1,000,000 1.6885%
9/9/25 Option

Chairman

1,000,000 1.6885%
9/9/25 Option

Chief Executive Officer

1,000,000 1.6885%
Change 5-day change 1-year change 3-year change Capi.($)
+33.33%+33.33%-33.33%-66.67% 885K
-1.17%-0.03%+18.70%+70.05% 48.37B
+0.04%+1.41%+54.88%+122.68% 39.88B
-1.36%-1.36%-11.21%+14.14% 12.05B
+2.27%+4.12%+16.41%+81.30% 11.77B
+0.19%0.00%+30.98%+150.00% 9.19B
-0.45%+3.26%+24.53%+45.36% 7.87B
-1.26%+0.08%+52.63%-11.77% 7.25B
+1.60%+8.54%+25.00%+217.84% 7.1B
+0.95%-8.22%-39.88%+16.67% 5.26B
Average +3.42%+0.62%+13.87%+63.96% 14.87B
Weighted average by Cap. -0.27%+1.17%+26.75%+85.33%

Financials

2024 2025
Net sales 0 0 0 0 0 0.28 0 0.03 0.01 0.14 0.01 0.01 0.46 -
Net income -73.2K -52.71K -45.24K -42.46K -38.78K -5.03M -73.55K -503K -195K -2.54M -198K -194K -8.4M -335K -241K -207K -194K -178K -23.01M -337K -2.3M -891K -11.61M -906K -886K -38.45M
Net Debt 804K 579K 497K 467K 426K 55.24M 808K 5.52M 2.14M 27.87M 2.17M 2.13M 92.3M 999K 720K 618K 580K 529K 68.64M 1M 6.86M 2.66M 34.63M 2.7M 2.64M 115M
Logo Genix Pharmaceuticals Corporation
Genix Pharmaceuticals Corporation is a Canadian ophthalmic drugs company. The Company is a formulator, manufacturer, licensor and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its operations consist primarily of the research, development, manufacture, in-licensing and sales of novel and healthcare products, focusing on proprietary over the counter (OTC) nutraceuticals and generic pharmaceuticals. The Company has been marketing and selling other nutraceuticals and some pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels and spirulina powder. Its products include Ketorolac 0.5% Eye Drops, Timolol 0.5% Eye Drops, Diclofenac 0.1% Eye Drops, Moxifloxacin Hydrochloride 0.5% Eye Drops, Prednisolone Acetate 1% Eye Drops, Olopatadine 0.1% Eye Drops, and others.
Employees
4,000
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. GENX Stock